SCHEMBL6212014

SCHEMBL6212014

O=C(O)c1ccc(C(O)c2ccc3ccc(C(=O)NCc4ccc5c(c4)CCN5)cc3c2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H4 Q96RI1 7/20 0.48
EPHX2 P34913 4/20 0.39
KDM4E B2RXH2 1/20 0.39
MAPT P10636 1/20 0.39
HDAC3 O15379 1/20 0.38
HDAC4 P56524 1/20 0.38
HDAC1 Q13547 1/20 0.38
HDAC7 Q8WUI4 1/20 0.38
HDAC2 Q92769 1/20 0.38
HDAC10 Q969S8 1/20 0.38
HDAC11 Q96DB2 1/20 0.38
HDAC8 Q9BY41 1/20 0.38
HDAC6 Q9UBN7 1/20 0.38
HDAC9 Q9UKV0 1/20 0.38
HDAC5 Q9UQL6 1/20 0.38
MMP13 P45452 1/20 0.37
CYP4F2 P78329 1/20 0.36
CYP4A11 Q02928 1/20 0.36
MAPK14 Q16539 1/20 0.36
PLAU P00749 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6210414 0.86 NR1H4 (0.52) NR1H4EPHX2KDM4EMAPTHDAC3
SCHEMBL6212525 0.83 RXRB (0.40) KDM4EMAPTRARARARBRARG
SCHEMBL6193966 0.81 NR1H4 (0.48) NR1H4EPHX2MAPTHDAC3HDAC4
SCHEMBL6843097 0.81 RAB9A (0.58) NR1H4EPHX2MAPTMMP13
SCHEMBL6213479 0.80 NR1H4 (0.47) NR1H4EPHX2KDM4EMAPTHDAC3
SCHEMBL6194056 0.79 NR1H4 (0.68) NR1H4EPHX2HDAC3HDAC4HDAC1
SCHEMBL6195421 0.79 NR1H4 (0.57) NR1H4EPHX2HDAC3HDAC4HDAC1
SCHEMBL6193273 0.79 NR1H4 (0.60) NR1H4EPHX2HDAC3HDAC4HDAC1
SCHEMBL6194634 0.79 NR1H4 (0.60) NR1H4EPHX2HDAC3HDAC4HDAC1
SCHEMBL6191909 0.79 NR1H4 (0.60) NR1H4EPHX2HDAC3HDAC4HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1539163-A1 4-HYDROXYQUINOLINE DERIVATIVES AS MATRIX METALLOPROTEINASE INHIBITORS Warner-Lambert Company LLC (US) 2005-06-15 EP disclosed
US-20040043983-A1 Naphthalene derivatives as matrix metalloproteinase inhibitors LI JIE JACK (US) 2004-03-04 US disclosed
WO-2004014377-A1 4-HYDROXYQUINOLINE DERIVATIVES AS MATRIX METALLOPROTEINASE INHIBITORS WARNER-LAMBERT COMPANY LLC (US) 2004-02-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040043983-A1 Naphthalene derivatives as matrix metalloproteinase inhibitors MMP9, MMP8, MMP13 NR1H4 1615/4885EPHX2 2569/4885KDM4E 1987/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.